Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease

Bibliographic Details
Main Author: Jian Xu
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Translational Medicine
Online Access:https://doi.org/10.1186/s12967-023-03965-3
_version_ 1811165747048611840
author Jian Xu
author_facet Jian Xu
author_sort Jian Xu
collection DOAJ
first_indexed 2024-04-10T15:41:39Z
format Article
id doaj.art-08f63de72e674a8a8ba6c1841c25bbf0
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-10T15:41:39Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-08f63de72e674a8a8ba6c1841c25bbf02023-02-12T12:21:04ZengBMCJournal of Translational Medicine1479-58762023-02-012111310.1186/s12967-023-03965-3Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe diseaseJian Xu0Department of Infectious Disease, The People’s Hospital of Yubei District of Chongqing Cityhttps://doi.org/10.1186/s12967-023-03965-3
spellingShingle Jian Xu
Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
Journal of Translational Medicine
title Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
title_full Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
title_fullStr Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
title_full_unstemmed Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
title_short Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
title_sort bi anti therapy for sars cov 2 infection among mild moderate patients to prevent coronavirus disease 2019 from progressing to severe disease
url https://doi.org/10.1186/s12967-023-03965-3
work_keys_str_mv AT jianxu biantitherapyforsarscov2infectionamongmildmoderatepatientstopreventcoronavirusdisease2019fromprogressingtoseveredisease